For: | Voutsadakis IA. Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies. World J Gastroenterol 2020; 26(11): 1197-1207 [PMID: 32231423 DOI: 10.3748/wjg.v26.i11.1197] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i11/1197.htm |
Number | Citing Articles |
1 |
Guo Long, Kuan Hu, Xiaofang Zhang, Ledu Zhou, Juanni Li. Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-31109-6
|
2 |
Mónica Arranz-Ledo, Mar Infante, Enrique Lastra, Amaya Olaverri, Marta Orozco, Lucia C. Mateo, Noemí Martínez, Lara Hernández, Mercedes Durán. Genetic Features of Tumours Arising in the Context of Suspected Hereditary Cancer Syndromes with RAD50, RAD51C/D, and BRIP1 Germline Mutations, Results of NGS-Reanalysis of BRCA/MMR-Negative Families. Genes 2025; 16(4): 458 doi: 10.3390/genes16040458
|
3 |
Antonella Pietragalla, Martina Arcieri, Claudia Marchetti, Giovanni Scambia, Anna Fagotti. Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes. International Journal of Gynecological Cancer 2020; 30(11): 1803 doi: 10.1136/ijgc-2020-001556
|
4 |
Haohui Xu, Yixin Zhang, Caiqin Wang, Zhuoyan Fu, Jing Lv, Yufang Yang, Zihan Zhang, Yuanmin Qi, Kai Meng, Jinxiang Yuan, Xiaomei Wang. Research progress on the fanconi anemia signaling pathway in non-obstructive azoospermia. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1393111
|
5 |
Hiroo Fujitani, Hidetaka Eguchi, Yuta Kochi, Tomio Arai, Masaaki Muramatsu, Yasushi Okazaki. Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study. European Journal of Cancer Prevention 2023; 32(3): 286 doi: 10.1097/CEJ.0000000000000787
|
6 |
Livia Archibugi, Fabio Casciani, Silvia Carrara, Erica Secchettin, Massimo Falconi, Gabriele Capurso, Salvatore Paiella. The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals. Familial Cancer 2024; 23(3): 373 doi: 10.1007/s10689-024-00366-3
|
7 |
Ioannis A. Voutsadakis, Antonia Digklia. The Landscape and Therapeutic Targeting of BRCA1, BRCA2 and Other DNA Damage Response Genes in Pancreatic Cancer. Current Issues in Molecular Biology 2023; 45(3): 2105 doi: 10.3390/cimb45030135
|
8 |
Guan Wang, Zhijian Ren, Yang Zhao, Yumin Li. A nine-gene signature as prognostic biomarker in gastric cancer by bioinformatics analysis. Clinical and Translational Oncology 2023; 25(11): 3296 doi: 10.1007/s12094-023-03180-y
|
9 |
Pedram Argani, Carla Saoud, Cristina R. Antonescu. Molecular Analysis of Renal/Adrenal Angiosarcomas Reveals High Frequency of Recurrent Genetic Alterations. Genes, Chromosomes and Cancer 2024; 63(9) doi: 10.1002/gcc.23268
|
10 |
Bayanika Manunu, Antonio M. Serafin, John M. Akudugu. BAG1, MGMT, FOXO1, and DNAJA1 as potential drug targets for radiosensitizing cancer cell lines. International Journal of Radiation Biology 2023; 99(2): 292 doi: 10.1080/09553002.2022.2074164
|
11 |
Saba Selvi, Carmen Macías Real, Manuel Gentiluomo, Katerina Balounova, Klara Vokacova, Andrea Cumova, Beatrice Mohlenikova-Duchonova, Cosmeri Rizzato, Erika Halasova, Ludmila Vodickova, Bozena Smolkova, Kari Hemminki, Daniele Campa, Pavel Vodicka. Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer. Seminars in Cancer Biology 2025; 113: 59 doi: 10.1016/j.semcancer.2025.05.005
|
12 |
Mengting Zhu, Pengfei Li, Weiwei Wu, Wenxin Zheng, Juncheng Huang, Hanikzi Tulafu, Changchun Lin, Weikun Tao, Qi Aladaer. The genetic characterization of germplasm and identification of the litter size trait associated candidate genes in Dexin mutton and fine-wool sheep. Frontiers in Genetics 2024; 15 doi: 10.3389/fgene.2024.1457634
|
13 |
Eunji Yim, Denise Leung. Leptomeningeal disease in BRIP1-mutated pancreatic adenocarcinoma. BMJ Case Reports 2022; 15(6): e249837 doi: 10.1136/bcr-2022-249837
|